DaVita
DVA
#1619
Rank
โ‚ฌ11.73 B
Marketcap
182,83ย โ‚ฌ
Share price
0.77%
Change (1 day)
53.72%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): 9,40ย โ‚ฌ

According to DaVita's latest financial reports the company's current EPS (TTM) is 9,55ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 8,79ย โ‚ฌ a decrease over its 2024 EPS that were of 9,58ย โ‚ฌ.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)9,40ย โ‚ฌ6.93%
20258,79ย โ‚ฌ-8.25%
20249,58ย โ‚ฌ44.94%
20236,61ย โ‚ฌ27.26%
20225,19ย โ‚ฌ-35.56%
20218,06ย โ‚ฌ44.1%
20205,59ย โ‚ฌ19.7%
20194,67ย โ‚ฌ540.48%
20180,73ย โ‚ฌ-76.07%
20173,05ย โ‚ฌ-19.31%
20163,78ย โ‚ฌ242.52%
20151,10ย โ‚ฌ-62.87%
20142,97ย โ‚ฌ13.43%
20132,62ย โ‚ฌ8.45%
20122,41ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
21,11ย โ‚ฌ 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
9,86ย โ‚ฌ 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
16,89ย โ‚ฌ 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
1,68ย โ‚ฌ-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA